P. Lescuyer, M. Chevallet, and T. Rabilloud, L???analyse prot??omique : concepts, r??alit??s et perspectives en th??rapeutique, m??decine/sciences, vol.20, issue.5, pp.587-92, 2004.
DOI : 10.1051/medsci/2004205587

M. Lim and K. Elenitoba-johnson, Proteomics in pathology research, Laboratory Investigation, vol.12, issue.10, pp.1227-1271, 2004.
DOI : 10.1038/labinvest.3700167

B. Chong, D. Lubman, A. Rosenspire, and F. Miller, Protein profiles and identification of high performance liquid chromatography isolated proteins of cancer cell lines using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, Rapid Communications in Mass Spectrometry, vol.12, issue.24, pp.1986-93, 1998.
DOI : 10.1002/(SICI)1097-0231(19981230)12:24<1986::AID-RCM419>3.0.CO;2-H

O. Neil, K. Miller, F. Barder, T. Lubman, and D. , Profiling the progression of cancer: separation of microsomal proteins in MCF10 breast epithelial cell lines using nonporous chromatophoresis, Proteomics, vol.3, pp.1256-69, 2003.

K. Zhu, J. Kim, and C. Yoo, High Sequence Coverage of Proteins Isolated from Liquid Separations of Breast Cancer Cells Using Capillary Electrophoresis-Time-of-Flight MS and MALDI-TOF MS Mapping, Analytical Chemistry, vol.75, issue.22, pp.6209-6226, 2003.
DOI : 10.1021/ac0346454

H. Issaq, T. Veenstra, T. Conrads, and D. Felschow, The SELDI-TOF MS Approach to Proteomics: Protein Profiling and Biomarker Identification, Biochemical and Biophysical Research Communications, vol.292, issue.3, pp.587-92, 2002.
DOI : 10.1006/bbrc.2002.6678

E. Petricoin, A. Ardekani, and B. Hitt, Use of proteomic patterns in serum to identify ovarian cancer, The Lancet, vol.359, issue.9306, pp.572-579, 2002.
DOI : 10.1016/S0140-6736(02)07746-2

E. Diamandis, Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool: Opportunities and Potential Limitations, Molecular & Cellular Proteomics, vol.3, issue.4, pp.367-78, 2004.
DOI : 10.1074/mcp.R400007-MCP200

Z. Zhang, R. Bast, J. Yu, and Y. , Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer, Cancer Research, vol.64, issue.16, pp.5882-90, 2004.
DOI : 10.1158/0008-5472.CAN-04-0746

E. Diamandis, Proteomic patterns in serum and identification of ovarian cancer, The Lancet, vol.360, issue.9327, 2002.
DOI : 10.1016/S0140-6736(02)09390-X

E. Diamandis, Analysis of Serum Proteomic Patterns for Early Cancer Diagnosis: Drawing Attention to Potential Problems, JNCI Journal of the National Cancer Institute, vol.96, issue.5, pp.353-359, 2004.
DOI : 10.1093/jnci/djh056

L. Coussens and Z. Werb, Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002.
DOI : 10.1006/cyto.1996.0074

A. Mehta, S. Ross, and M. Lowenthal, Biomarker Amplification by Serum Carrier Protein Binding, Disease Markers, vol.19, issue.1, pp.1-10, 2003.
DOI : 10.1155/2003/104879

L. Liotta, M. Ferrari, and E. Petricoin, Clinical proteomics: Written in blood, Nature, vol.425, issue.6961, p.905, 2003.
DOI : 10.1038/425905a

S. Mok, J. Chao, and S. Skates, Prostasin, a Potential Serum Marker for Ovarian Cancer: Identification Through Microarray Technology, JNCI Journal of the National Cancer Institute, vol.93, issue.19, pp.1458-64, 2001.
DOI : 10.1093/jnci/93.19.1458

L. Matrisian, G. Sledge, J. Mohla, and S. , Extracellular proteolysis and cancer: meeting summary and future directions, Cancer Res, vol.63, pp.6105-6114, 2003.

G. Yousef and E. Diamandis, The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to Disease, Endocrine Reviews, vol.22, issue.2, pp.184-204, 2001.
DOI : 10.1210/er.22.2.184

E. Petricoin and L. Liotta, The Vision for a New Diagnostic Paradigm, Clinical Chemistry, vol.49, issue.8, pp.1276-1284, 2003.
DOI : 10.1373/49.8.1276

E. Diamandis, Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?, Clinical Chemistry, vol.49, issue.8, pp.1272-1277, 2003.
DOI : 10.1373/49.8.1272

J. Solassol, P. Marin, and E. Demettre, Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection, Analytical Biochemistry, vol.338, issue.1, pp.26-31, 2005.
DOI : 10.1016/j.ab.2004.11.031

K. Merrell, K. Southwick, and S. Graves, Analysis of low-abundance, lowmolecular-weight serum proteins using mass spectrometry, J Biomol Tech, vol.15, pp.238-286, 2004.

Y. Wang, P. Cheng, and D. Chan, A simple affinity spin tube filter method for removing high-abundant common proteins or enriching low-abundant biomarkers for serum proteomic analysis, PROTEOMICS, vol.3, issue.3, pp.243-251, 2003.
DOI : 10.1002/pmic.200390036

N. Govorukhina, A. Keizer-gunnink, and A. Van-der-zee, Sample preparation of human serum for the analysis of tumor markers, Journal of Chromatography A, vol.1009, issue.1-2, pp.171-179, 2003.
DOI : 10.1016/S0021-9673(03)00921-X

E. Petricoin, D. Ornstein, and C. Paweletz, Serum Proteomic Patterns for Detection of Prostate Cancer, CancerSpectrum Knowledge Environment, vol.94, issue.20, pp.1576-1584, 2002.
DOI : 10.1093/jnci/94.20.1576

K. Kozak, M. Amneus, and S. Pusey, Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis, Proceedings of the National Academy of Sciences, vol.1, issue.7, pp.12343-12351, 2003.
DOI : 10.1002/1615-9861(200107)1:7<890::AID-PROT890>3.0.CO;2-Z

B. Ye, D. Cramer, and S. Skates, Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer : identification and characterization using proteomic profiling and mass spectrometry, Clin Cancer Res, vol.9, pp.2904-2915, 2003.

B. Adam, Y. Qu, and J. Davis, Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men, Cancer Res, vol.62, pp.3609-3623, 2002.

Y. Qu, B. Adam, and Y. Yasui, Boosted decision tree analysis of surfaceenhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients, Clin Chem, vol.48, pp.1835-1878, 2002.

L. Banez, P. Prasanna, and L. Sun, Diagnostic Potential of Serum Proteomic Patterns in Prostate Cancer, The Journal of Urology, vol.170, issue.2, pp.442-448, 2003.
DOI : 10.1097/01.ju.0000069431.95404.56

S. Lehrer, J. Roboz, and H. Ding, Putative protein markers in the sera of men with prostatic neoplasms, BJU International, vol.43, issue.Suppl. 4A, pp.223-228, 2003.
DOI : 10.1046/j.1464-410X.2003.04341.x

J. Hlavaty, A. Partin, and M. Shue, Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer, Urology, vol.61, issue.6, pp.1261-1266, 2003.
DOI : 10.1016/S0090-4295(03)00036-0

L. Cazares, B. Adam, and M. Ward, Normal, benign, preneoplastic, and malignant prostate cells have distinct protein expression profiles resolved by surface enhanced laser desorption/ionization mass spectrometry, Clin Cancer Res, vol.8, pp.2541-52, 2002.

A. Wellmann, V. Wollscheid, and H. Lu, Analysis of microdissected prostate tissue with ProteinChip?? arrays - a way to new insights into carcinogenesis and to diagnostic tools, International Journal of Molecular Medicine, vol.9, pp.341-348, 2002.
DOI : 10.3892/ijmm.9.4.341

J. Koopmann, Z. Zhang, and N. White, Serum Diagnosis of Pancreatic Adenocarcinoma Using Surface-Enhanced Laser Desorption and Ionization Mass Spectrometry, Clinical Cancer Research, vol.10, issue.3, pp.860-868, 2004.
DOI : 10.1158/1078-0432.CCR-1167-3

C. Rosty, C. L. Kuzdzal, and S. , Identification of hepatocarcinoma-intestinepancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology, Cancer Res, vol.62, pp.1868-75, 2002.

A. Vlahou, C. Laronga, and L. Wilson, A Novel Approach Toward Development of a Rapid Blood Test for Breast Cancer, Clinical Breast Cancer, vol.4, issue.3, pp.203-212, 2003.
DOI : 10.1016/S1526-8209(11)70627-9

J. Li, Z. Zhang, and J. Rosenzweig, Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer, Clin Chem, vol.48, pp.1296-304, 2002.

S. Becker, L. Cazares, and P. Watson, Surfaced-Enhanced Laser Desorption/Ionization Time-of-Flight (SELDI-TOF) Differentiation of Serum Protein Profiles of BRCA-1 and Sporadic Breast Cancer, Annals of Surgical Oncology, vol.21, issue.10, pp.907-921, 2004.
DOI : 10.1245/ASO.2004.03.557

L. Pusztai, B. Gregory, and K. Baggerly, Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma, Cancer, vol.80, issue.9, pp.1814-1836, 2004.
DOI : 10.1002/cncr.20203

C. Paweletz, B. Trock, and M. Pennanen, Proteomic Patterns of Nipple Aspirate Fluids Obtained by SELDI-TOF: Potential for New Biomarkers to Aid in the Diagnosis of Breast Cancer, Disease Markers, vol.17, issue.4, pp.301-308, 2001.
DOI : 10.1155/2001/674959

E. Sauter, S. Shan, and J. Hewett, Proteomic analysis of nipple aspirate fluid using SELDI-TOF-MS, International Journal of Cancer, vol.8, issue.5, p.17, 2004.
DOI : 10.1002/ijc.20742

H. Kuerer, K. Coombes, and J. Chen, Association between ductal fluid proteomic expression profiles and the presence of lymph node metastases in women with breast cancer, Surgery, vol.136, issue.5, pp.1061-1070, 2004.
DOI : 10.1016/j.surg.2004.04.011

T. Zhukov, R. Johanson, and A. Cantor, Discovery of distinct protein profiles specific for lung tumors and pre-malignant lung lesions by SELDI mass spectrometry, Lung Cancer, vol.40, issue.3, pp.267-79, 2003.
DOI : 10.1016/S0169-5002(03)00082-5

X. Xiao, D. Liu, and Y. Tang, Development of Proteomic Patterns for Detecting Lung Cancer, Disease Markers, vol.19, issue.1, pp.33-42, 2003.
DOI : 10.1155/2003/278152

M. Rogers, C. P. Noble, and J. , Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis : identification of key issues affecting potential clinical utility, Cancer Res, vol.63, pp.6971-83, 2003.

Y. Won, H. Song, and T. Kang, Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons, PROTEOMICS, vol.3, issue.12, pp.2310-2316, 2003.
DOI : 10.1002/pmic.200300590

S. Soltys, Q. Le, and G. Shi, The Use of Plasma Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Proteomic Patterns for Detection of Head and Neck Squamous Cell Cancers, Clinical Cancer Research, vol.10, issue.14, pp.4806-4818, 2004.
DOI : 10.1158/1078-0432.CCR-03-0469

J. Wadsworth, K. Somers, B. Stack, and . Jr, Identification of Patients With Head and Neck Cancer Using Serum Protein Profiles, Archives of Otolaryngology???Head & Neck Surgery, vol.130, issue.1, pp.98-104, 2004.
DOI : 10.1001/archotol.130.1.98

C. Melle, G. Ernst, and B. Schimmel, Biomarker discovery and identification in laser microdissected head and neck squamous cell carcinoma with ProteinChip(R) technology, two-dimensional gel electrophoresis, tandem mass spectrometry and immunohistochemistry, Molecular & Cellular Proteomics, vol.2, pp.443-52, 2003.
DOI : 10.1074/mcp.M300033-MCP200

C. Melle, R. Kaufmann, and M. Hommann, Proteomic profiling in microdissected hepatocellular carcinoma tissue using ProteinChip?? technology, International Journal of Oncology, vol.24, pp.885-91, 2004.
DOI : 10.3892/ijo.24.4.885

L. Wilson, L. Tran, D. Morton, and D. Hoon, Detection of Differentially Expressed Proteins in Early-Stage Melanoma Patients Using SELDI-TOF Mass Spectrometry, Annals of the New York Academy of Sciences, vol.2, issue.1
DOI : 10.1196/annals.1318.047

A. Vlahou, P. Schellhammer, and S. Mendrinos, Development of a Novel Proteomic Approach for the Detection of Transitional Cell Carcinoma of the Bladder in Urine, The American Journal of Pathology, vol.158, issue.4
DOI : 10.1016/S0002-9440(10)64100-4

R. Krieg, F. Fogt, and T. Braunschweig, ProteinChip array analysis of microdissected colorectal carcinoma and associated tumor stroma shows specific protein bands in the 3.4 to 3.6 kDa range, Anticancer Res, vol.24, pp.1791-1797, 2004.

M. Shiwa, Y. Nishimura, and R. Wakatabe, Rapid discovery and identification of a tissue-specific tumor biomarker from 39 human cancer cell lines using the SELDI ProteinChip platform, Biochemical and Biophysical Research Communications, vol.309, issue.1, pp.18-25, 2003.
DOI : 10.1016/S0006-291X(03)01520-1

Y. Chen, S. Zheng, J. Yu, and X. Hu, Artificial Neural Networks Analysis of Surface-Enhanced Laser Desorption/Ionization Mass Spectra of Serum Protein Pattern Distinguishes Colorectal Cancer from Healthy Population, Clinical Cancer Research, vol.10, issue.24, pp.8380-8385, 2004.
DOI : 10.1158/1078-0432.CCR-1162-03

Y. Wong, T. Cheung, and K. Lo, Protein profiling of cervical cancer by protein-biochips: proteomic scoring to discriminate cervical cancer from normal cervix, Cancer Letters, vol.211, issue.2, pp.227-261, 2004.
DOI : 10.1016/j.canlet.2004.02.014